This increases companies exposure to fluctuating raw material costs and volatile supplies
CrossRef Advances in small-molecule insulin secretagogues for diabetes treatment Jingqian Su, Jingran Xu, Shan Hu, Hui Ye, Lian Xie, Songying Ouyang Biomedicine & Pharmacotherapy.2024
characteristics and goal achievement of patients with type 2 diabetes mellitus treated with basal insulin and physician-perceived barriers to achieving glycemic targets
Prescription drug rebates and formulary placement: Evidence from the Medicare Part D program
This warning is based on animal studies, where some rats developed thyroid tumors after receiving semaglutide (the active ingredient in Ozempic)
No tolerance development has been documented, suggesting ongoing benefits with consistent use